CLINICAL ROLE -
Advancing Treatment Selection in CLL Management
Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.
Read More
Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population
Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.
Treatment Opportunities Continue to Advance in CLL Management
In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.
Novel Drug Combinations in Precision Medicine Are an Emerging Landscape for Pharmacists
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease
Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest Outcomes in Adult Patients With Ph+ ALL Using TKIs With Modified USC Regimen
Substantial strides have been made in the management of Ph+ ALL.
Real-World Efficacy, Safety of Tixagevimab/Cilgavimab in Patients With Cancer After EUA Revision
The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.
FLT3 Inhibitors Sustain Prolonged Remission in AML Post HSCT
A retrospective analysis presents unique results for AML treatment.